Cargando…
Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
BACKGROUND AND AIM: Data on the radiologic evaluation of perianal fistulizing Crohn’s disease (PFCD) naïve to anti-tumor necrosis factor therapy are scarce, especially in Asian populations. We assessed the effectiveness of infliximab (IFX) on PFCD and explored predictors of ‘deep remission’ based on...
Autores principales: | Yan, Xiaohan, Zhu, Mingming, Feng, Qi, Yan, Yunqi, Peng, Jiangchen, Xu, Xitao, Xu, Antao, Ran, Zhihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375345/ https://www.ncbi.nlm.nih.gov/pubmed/30792866 http://dx.doi.org/10.1093/gastro/goy036 |
Ejemplares similares
-
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020) -
Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease
por: Thomassin, Lucie, et al.
Publicado: (2017) -
Analysis of Risk Factors for Anorectal Stenosis of Perianal Fistulizing Crohn’s Disease
por: Xu, MinMin, et al.
Publicado: (2020) -
Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018) -
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022)